210 results on '"McKay, Kyla A."'
Search Results
2. Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis
3. Medication use and risk of amyotrophic lateral sclerosis—a systematic review
4. Epidemiology of Multiple Sclerosis and Environmental Risk Factors
5. Incidence rate and prevalence of pediatric‐onset multiple sclerosis in Sweden: A population‐based register study
6. Association of pre-existing maternal cardiovascular diseases with neurodevelopmental disorders in offspring: a cohort study in Sweden and British Columbia, Canada
7. Disclosing or concealing multiple sclerosis in the workplace: two sides of the same coin—insights from a Swedish population-based survey.
8. Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study.
9. Incidence and prevalence of paediatric-onset multiple sclerosis in two Canadian provinces: a populationbased study representing over half of Canada's population.
10. Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide study
11. Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care Context
12. Socioeconomic status and quality of multiple sclerosis care in Sweden
13. Association of pre-existing maternal cardiovascular diseases with neurodevelopmental disorders in offspring: a cohort study in Sweden and British Columbia, Canada.
14. Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis
15. Physical activity and disability outcomes in multiple sclerosis: A systematic review (2011–2016)
16. Familial risk of early- and late-onset multiple sclerosis: a Swedish nationwide study
17. Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study
18. Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab
19. Incidence and prevalence of paediatric-onset multiple sclerosis in two Canadian provinces: a population-based study representing over half of Canada’s population
20. Determinants of neurological disease: Synthesis of systematic reviews
21. Genetic variation associated with the occurrence and progression of neurological disorders
22. Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review
23. Determinants of quality of life in pediatric- and adult-onset multiple sclerosis
24. Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort study
25. Association of pre-existing maternal cardiovascular diseases with neurodevelopmental disorders in offspring: a cohort study in Sweden and British Columbia, Canada
26. Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study
27. Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes
28. sj-docx-1-msj-10.1177_13524585231181578 – Supplemental material for Association between clinic-level quality of care and patient-level outcomes in multiple sclerosis
29. sj-docx-1-msj-10.1177_13524585231161492 – Supplemental material for Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study
30. Long-term disability progression of pediatric-onset multiple sclerosis
31. T55. POLYGENICITY OF COMORBID DEPRESSION IN MULTIPLE SCLEROSIS
32. Association between brain volume and disability over time in multiple sclerosis
33. Pre-pregnancy maternal cardiovascular diseases and risk of offspring’s neurodevelopmental disorders: a population-based cohort study.
34. COVID‐19 clinical outcomes and DMT of MS patients and population‐based controls
35. Drug exposure and the risk of multiple sclerosis: A systematic review
36. Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study
37. Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study.
38. Polygenicity of Comorbid Depression in Multiple Sclerosis
39. sj-docx-1-mso-10.1177_20552173221144230 - Supplemental material for Association between brain volume and disability over time in multiple sclerosis
40. Additional file 1 of Medication use and risk of amyotrophic lateral sclerosis—a systematic review
41. sj-docx-2-mso-10.1177_20552173221144230 - Supplemental material for Association between brain volume and disability over time in multiple sclerosis
42. sj-docx-3-mso-10.1177_20552173221144230 - Supplemental material for Association between brain volume and disability over time in multiple sclerosis
43. Reduction in Cognitive Processing Speed Surrounding Multiple Sclerosis Relapse
44. Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden
45. Administrative data for observational research in multiple sclerosis: Opportunities and challenges
46. Validating the diagnosis of multiple sclerosis using Swedish administrative data in Värmland County
47. Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry
48. Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry.
49. Long-term socioeconomic outcomes associated with pediatric-onset multiple sclerosis: A nationwide prospective cohort study (4090)
50. Long-term Socioeconomic Outcomes Associated With Pediatric-Onset Multiple Sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.